With All Eyes On Lecanemab Read Out In Alzheimer’s, Uncertainty Overshadows Biogen’s Q2 Beat
July 21, 3:44 PM
Yesterday, Biogen Inc (NASDAQ:BIIB) reported Q2 earnings. Needham writes that while operational performance looked good, uncertainty looms over the company’s growth potential. Lecanemab Phase…
This Analyst Says Invitae’s Current Valuation ‘Not Accommodative’
July 21, 3:28 PM
Raymond James has downgraded Invitae Corp (NYSE:NVTA) to Market Perform from Outperform following news of a full reset, including leadership changes…
How To Trade Snap Stock Before And After Q2 Earnings
July 21, 3:26 PM
Snap, Inc (NYSE: SNAP) is set to print its second-quarter financial results after the markets close on Thursday.
American Express, Intel Get CNBC Fast Money Mentions, With This Stock Jumping 1.8% In Seconds
July 21, 3:01 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
ADM Partners With Farmers Business Network On Sustainable AgTech Platform
July 21, 2:54 PM
Archer-Daniels-Midland Co (NYSE:ADM) has signed an agreement with FBN (Farmers Business Network) to expand the availability of FBN’s digital farm business…
Visionary Education Acquires 100% Equity Interest In Griggs China
July 21, 2:36 PM
Visionary Education Technology Holdings Group Inc (NASDAQ: VEDU) subsidiary entered an agreement to acquire a 100% equity interest in Griggs International Academy China Co. Ltd. (Griggs China).
Why This Palantir Analyst Says Stock Is A ‘Unicorn’ That Could Double In 1 Year
July 21, 2:17 PM
Palantir Technologies Inc (NYSE: PLTR) was initiated with a Strong Buy rating with a $20 price target Thursday from Raymond James, which called the software company a “cultural unicorn." Here's what you need to know.
Blue Bird Launches Energy Services For School Bus Fleets
July 21, 2:09 PM
Blue Bird Corp (NASDAQ: BLBD) has launched its Blue Bird Energy Services business to accelerate the electrification of the student transportation industry.…
Analysts Cut Bath & Body Works’ Price Target Post Outlook Revision
July 21, 2:03 PM
Telsey Advisory Group analyst Dana Telsey reiterated Outperform rating on Bath & Body Works Inc (NYSE: BBWI) and lowered the price target to $40 from $60 (23% upside)